Bussolati
Benedetta Bussolati, Moncalieri (torino) IT
Patent application number | Description | Published |
---|---|---|
20100003752 | Liver progenitor cells - The invention relates to human liver pluripotent progenitor cell lines which express hepatic cell markers such as albumin and α-fetoprotein and do not express some of the markers which are typical of oval stem cells. Also disclosed is a method of isolating the cell lines of the invention, methods for differentiating said cells into a plurality of different cell lineages, methods for conditional immortalization and metabolic selection of said cells, as well as the use of the cell lines of the invention for preparing a medicament with osteogenic differentiation activity or liver injury regeneration activity. | 01-07-2010 |
Benedetta Bussolati, Torino IT
Patent application number | Description | Published |
---|---|---|
20110256111 | ISOLATED MULTIPOTENT MESENCHYMAL STEM CELL FROM HUMAN ADULT GLOMERULI (HGL-MSC), A METHOD OF PREPARING THEREOF AND USES THEREOF IN THE REGENERATIVE MEDICINE OF THE KIDNEY - The invention relates to an isolated multipotent glomerular mesenchymal stem cell derived from adult human kidney (hGL-MSC), which is characterised by the marker profile CD133 | 10-20-2011 |
Giovanni Bussolati, Torino IT
Patent application number | Description | Published |
---|---|---|
20090191533 | Process for Preserving Tissues - A process for preserving tissues is described which comprises transferring the tissues in a container and evacuating the container. | 07-30-2009 |
Rocco Bussolati, Parma IT
Patent application number | Description | Published |
---|---|---|
20150111931 | PROCESS FOR THE PREPARATION OF A PDE4 INHIBITOR - The present invention relates to a process for the preparation of compounds endowed with phosphodiesterase (PDE4) inhibitory activity having formula (I). The invention also relates to the process for the isolation by crystallization of the compound (I) and to its use for the preparation of pharmaceutical compositions for inhalation in combination with suitable carriers or vehicles. The present invention also relates to solvates and crystal forms of a compound of formula (I). The synthesized product is suitable for use in pharmaceutical applications for instance in the treatment of respiratory diseases. | 04-23-2015 |